MedTrace Logo

Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers

NCT04359576 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-04-20

No results posted yet for this study

Summary

The study focus on the impact of estrogen/progesterone substitution during artificial cycle frozen embryo transfer (AC-FET) in women undertaking assisted reproductive technology treatment (ART).

Conditions

  • Frozen Embryo Transfer

Interventions

DIAGNOSTIC_TEST

Primary and secondary hemostasis

Focus on platelet aggregation, primary and secondary hemostasis parameters

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • Horsens Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2022-03-31
Completion
2024-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04359576 on ClinicalTrials.gov